MedTrace Logo

Cancer Financial Experience

NCT05018000 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 371

Last updated 2026-01-12

No results posted yet for this study

Summary

This study is a randomized clinical trial designed to test a novel financial navigation intervention. The study assesses the impact of the financial navigation intervention on financial hardship and health-related quality of life, cancer-related material and psychological financial hardship, patient-centered communication, and time to initiation of treatment.

Conditions

Interventions

BEHAVIORAL

Enhanced usual care

The financial resource sheet lists and describes existing internal and community resources available to KP members

BEHAVIORAL

Financial navigation

The CAFÉ intervention is a financial navigation intervention. During the Intervention, a CAFÉ financial navigator will provide information support and resources to people with cancer after diagnosis. CAFÉ intervention components include: (1) proactive assessment of patient financial questions and concerns (e.g., acute financial need or inability to pay for household expenses; deciding between care options depending on cost; uncertainty around planning for out of pocket costs and/or when patients will need to pay), (2) proactive, personalized support and referrals.

Sponsors & Collaborators

  • Kaiser Permanente

    lead OTHER

Principal Investigators

  • Nora B Henrikson, PhD, MPH · Kaiser Permanente

  • Matthew Banegas, PhD, MPH, MS · University of California, San Diego

  • Amanda Petrik, PhDC, MS · Kaiser Permanente

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-11
Primary Completion
2025-03-01
Completion
2025-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05018000 on ClinicalTrials.gov